Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-09

Clinical Trial Update: Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy of Exposure and Response Prevention (ERP) and SSRIs in Chinese patients with Obsessive-Compulsive Disorder and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SSRIs (selective serotonin reuptake inhibitors)

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Obsessive-Compulsive Disorder, Anxiety Disorders | Phase 4 | Status: COMPLETED